HQIP / Resources / National Diabetes Audit, 2020-21 Report: Care processes and treatment targets
National Diabetes Audit, 2020-21 Report: Care processes and treatment targets
Published: 14 Jul 2022
The National Diabetes Audit (NDA) has published its annual report on care process completion and treatment target attainment. Based on data from 2020-21 in England and Wales, it describes the national picture in relation to NICE recommendations and targets for people with diabetes.
The report found that during the COVID-19 pandemic, care process completion declined everywhere but there was greater geographical variation than usual. The greatest impacts were on foot examination, weight measurement, and retinal screening. Urine albumin checks remain lowest. Other key findings include:
During the COVID-19 pandemic, glucose control improved in people with type 1 diabetes but deteriorated in those with type 2 and other types of diabetes; blood pressure deteriorated in all; and use of statins was relatively unchanged.
2% of those with type 1 diabetes and 5.3% with type 2 or other types of diabetes have severe frailty. 65,970 people with type 2 diabetes have both severe frailty and HbA1c ≤ 53 mmol/mol. 18,690 people with diabetes with severe frailty and HbA1c ≤ 53mmol/mol are on insulin or sulphonylurea or both. These people may be at particular risk of harm due to hypoglycaemia.
The report makes a number of recommendations, including a call to diabetes care providers and local systems to restore routine diabetes review (9 annual care processes) and work to reduce geographic variation.
Read the full report: You can read the report by clicking on the link below.
Stay up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.